| Code | Description | Claims | Beneficiaries | Total Paid |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,201 |
8,856 |
$141K |
| 80061 |
Lipid panel |
10,005 |
9,648 |
$125K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,858 |
2,377 |
$117K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,108 |
13,295 |
$100K |
| 80053 |
Comprehensive metabolic panel |
9,466 |
9,039 |
$91K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,340 |
2,228 |
$63K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,074 |
5,792 |
$55K |
| 81001 |
|
8,665 |
8,383 |
$28K |
| 84153 |
|
1,624 |
1,564 |
$27K |
| 36415 |
Collection of venous blood by venipuncture |
6,582 |
5,600 |
$27K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,144 |
1,005 |
$27K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,533 |
2,433 |
$20K |
| 82043 |
|
3,442 |
3,248 |
$20K |
| 86701 |
|
1,428 |
1,392 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
233 |
205 |
$12K |
| 82607 |
|
785 |
729 |
$11K |
| 87088 |
|
1,383 |
1,310 |
$10K |
| 81000 |
|
3,270 |
3,000 |
$10K |
| 82274 |
|
643 |
600 |
$10K |
| 86738 |
|
720 |
686 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
665 |
324 |
$8K |
| 84436 |
|
1,067 |
1,035 |
$7K |
| 82270 |
|
2,154 |
2,090 |
$7K |
| 84479 |
|
820 |
810 |
$5K |
| 82947 |
|
940 |
919 |
$3K |
| 84439 |
|
359 |
325 |
$3K |
| 80074 |
|
69 |
67 |
$3K |
| 87276 |
|
187 |
172 |
$2K |
| 82570 |
|
520 |
457 |
$2K |
| 86592 |
|
550 |
541 |
$2K |
| 85730 |
|
378 |
368 |
$2K |
| 85651 |
|
528 |
510 |
$2K |
| 85610 |
|
380 |
370 |
$1K |
| 80076 |
|
185 |
176 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
173 |
154 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
22 |
22 |
$1K |
| 86328 |
|
40 |
40 |
$949.86 |
| 80050 |
General health panel |
53 |
53 |
$518.71 |
| 82951 |
|
62 |
61 |
$396.26 |
| 82950 |
|
68 |
66 |
$288.06 |
| 82378 |
|
14 |
13 |
$250.76 |
| 86038 |
|
16 |
15 |
$193.29 |
| 86431 |
|
26 |
25 |
$147.88 |
| 86140 |
|
27 |
27 |
$116.72 |
| 82565 |
|
15 |
14 |
$48.21 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
20 |
20 |
$0.00 |